
usd jan pm et
summari compani develop manufactur market medic equip treatment
diagnosi sleep-disord breath
price-to-earnings oper ep
past perform indic futur perform reli upon
analysi prepar equiti analyst
oct pm stock trade
target price recent
chang highlight
section stock report updat
invest rationale/risk section
stock report updat shortli
latest news stori marketscop
lift target price
base discount cash flow
model reflect forward price-to-earnings vs
one-year rang
ep estim dec-q
ep vs beat consensu
estim
fy jun ep estim
fy ep
currenc cc million sale
mask accessori mask grew
cc global ahead market growth rate
mask sale growth led growth
america follow cc growth
rest world row mask sale
strong due recent product launch
increas patient adher result
devic sale grew cc global saa
revenu grew high-single-digit
exclud impact matrixcar
oper fairli competit market face
constant pressur third-parti payer howev
rmd product servic becom increasingli
accept compani histor maintain
manag level debt factor lead us
rate compani oper risk medium
apr ep estim base cfra oper earn
histor earn report compani report
stk
dividend paid sinc compani report
past perform indic futur perform
reli upon
forecast reliabl indic futur perform
redistribut reproduct prohibit without written permiss copyright cfra document intend provid person invest advic take account specif invest
object financi situat particular need specif person may receiv report investor seek independ financi advic regard suitabl and/or appropri make
invest implement invest strategi discuss document understand statement regard futur prospect may realiz investor note incom
invest may fluctuat valu invest may rise fall accordingli investor may receiv back less origin invest investor seek advic concern impact
invest may person tax posit tax advisor pleas note public date document may contain specif inform longer current use make
invest decis unless otherwis indic intent updat document
corpor overview resm inc engag develop manufactur distribut
medic equip treat diagnos manag respiratori disord includ
chronic diseas rmd product market approxim countri
compani portfolio product treatment obstruct sleep apnea osa form
sdb includ air flow gener diagnost product mask system headgear accessori
produc continu posit airway pressur cpap variabl posit airway pressur vpap
autoset system titrat treatment sdb market sleep record diagnosi
treatment sdb sleep clinic hospit also grow cloud-bas softwar
informat solut busi rmd out-of-hospit softwar product design support
profession caregiv help peopl stay healthi variou set outsid hospit
rmd devic air flow gener ventil oxygen concentr account approxim
fy jun revenu previou two year mask accessori motor
diagnost product account remain rmd fy revenu came saa
busi prior year
compani diagnost system record relev respiratori sleep data analyz
sleep specialist physician modifi appropri osa treatment regimen patient
assist profession diagnos manag treatment patient data
commun control product reslink rescontrol rescontrol ii txcontrol resscan
restraxx modul facilit transfer data inform flow
gener compani market variou product accessori includ humidifi
humidair connect directli cpap vpap autoset flow gener
humidifi heat air deliv patient option accessori includ cold passov
humidifi carri bag breath circuit
corpor strategi see growth sdb market futur attribut
posit number factor includ increas awar osa improv understand
role sdb treatment manag cardiac neurolog metabol relat disord
increas home-bas diagnosi busi strategi includ follow critic compon
continu product develop innov sdb respiratori care product expans
saa solut out-of-hospit care set expans geograph presenc increas
public clinic awar expans new clinic applic leverag experi
manag team
major develop made two major acquisit addit sever tuck-in
acquisit januari total purchas consider million acquir
propel health digit therapeut compani provid connect health solut peopl live
chronic obstruct pulmonari diseas asthma novemb acquir matrixcar inc
subsidiari provid softwar solut skill nurs life plan commun senior live
privat duti base purchas consider paid million
make major acquisit april acquir brightre llc
expand rmd offer includ suppli busi manag softwar servic
medic equip home health provid
financi trend fiscal year end june revenu increas
billion reflect five-year compound annual growth rate compound-annual-growth-rate adjust earn per share
increas year-over-year reflect five-year compound-annual-growth-rate free cash flow
million vs million june moder net debt total
capit ratio low leverag ratio net debt trailing-twelve-month ebitda
redistribut reproduct prohibit without prior written permiss copyright cfra
base cfra proprietari quantit model
stock rank overvalu
analysi stock current worth base
cfra proprietari quantit model suggest
overvalu usd
bullish sinc octob technic indic
bullish
figur base fiscal year-end price
growth rate averag
lt debt capit
return equiti
balanc sheet data million usd
oper
long term debt capit
net incom revenu
return asset
return equiti
 global market intellig data may preliminari restat result discontinu operations/speci item per share data adjust stock dividend ep dilut
redistribut reproduct prohibit without prior written permiss copyright cfra
fundament outlook health care
next month neutral expect
compani continu achiev robust organ
growth mid- high-single-digit revenu
growth driven new product
data provid estim world-wide medic
devic sale grow
time think potenti slowdown
macroeconom growth could pressur
industri driver yet sub-industri
includ mani product area
histor recession-resist
equip use non-elect procedur
gener see posit long-term
fundament medic devic manufactur
includ increas global demand
popul rise outlay
result steadi flow innov product
revenu growth
polit regulatori perspect
medic devic industri larg avoid
scrutini unlik area health
drug maker fact medic devic tax
final repeal decemb remov
signific risk sale devic maker
think industri continu
dwindl industri come back
favor especi sinc valuat health
rel
forward price-to-earn basi think
higher valuat sub-industri
mostli warrant margin expans
revenu growth opportun associ
 medic devic regul
mdr go effect may
follow vitro devic
regul ivdr goe effect
devic compani made much
commentari around introduct mdr
reason believ new
regul could neg impact
industri exampl juli
submit letter world trade
organ request mdr ivdr
delay three year also novemb
associ critic slow piecem
implement new regulatori
accord evalu
billion valu prior
five-year averag deal total
billion industri debt level measur
net debt rel total capit appear
declin substanti follow
sever year increas think
industri could see increas deal
especi new ceo sever
major firm
expect industri earn rise
low-double-digit percentag driven sale
new product command higher
margin project industri oper
ebit margin
estim margin
 health equip
valu composit index
 health equip
sub-index rose vs declin
base index
five-year market price perform jan
note sector sub-industri inform base
past perform indic futur perform
reli upon
yield equiti
ltd
peer group compani stock select issu base market capit
note peer select base global industri classif standard market capit peer group list includ compani similar characterist may includ compani within
industri and/or engag line busi
redistribut reproduct prohibit without prior written permiss copyright cfra
et cfra maintain hold opinion share resm inc
lower target ep
estim toward high end three-year price-to-earnings rang
dec-q ep vs higher estim lower
june ep estim ep
dec-q sale increas constant currenc million sale
america exclud saa grew year-over-year sale europ asia
market grew constant currenc basi expect
devic sale declin constant currenc term manag refrain
provid detail commentari factor drive
weaker-than-expect devic growth continu expand invest
digit health dec-q compani acquir propel health propel
offer platform help doctor better manag chronic obstruct pulmonari
diseas copd asthma /kevin huang cfa
et cfra maintain hold opinion share inc
lift target above-p
ep estim technolog leader
under-penetrated sleep apnea market sep-q ep vs
higher estim keep fy jun ep estim rais
fy ep sep-q sale increas constant
currenc million sale america exclud saa grow
year-over-year sale europ asia market grow
constant currenc basi expect incom center medicar
competit bid program posit patient healthcar
provid compani also seen posit reimburs chang
sever countri past month franc japan toward
digit health technolog expect grow global accept benefit
analyst research note compani news
pm et cfra keep hold opinion share resm inc
lift target price base discount cash flow
model reflect forward price-to-earnings vs one-year rang
ep estim dec-q ep vs beat
consensu estim stronger-than-expect mask sale
rais fy jun ep estim fy ep
dec-q sale increas yoy constant currenc
cc million sale mask accessori
mask grew cc global ahead market growth rate mask sale growth
led growth america follow cc growth rest
world row mask sale strong due recent product launch
increas patient adher result rmd digit health solut
meanwhil devic sale grew cc global saa revenu grew
high-single-digit exclud impact matrixcar acquisit
et cfra keep hold opinion share resm inc
rais target price base ep
estim high-end price-to-earnings rang
promis growth opportun sep-q ep vs exceed
estim rais fy jun ep estim
fy ep sep-q sale increas
constant currenc cc million expect
led cc growth global sale mask accessori strength
mask aid four new mask launch past year organ
basi saa busi grew high singl digit aim exit
fy solid double-digit growth saa busi
meanwhil devic busi grew cc in-lin fy devic growth
sep-q gross margin expand bp primarili due manufactur
procur effici aid higher margin contribut
et cfra keep hold opinion share resm inc
lift target price base ep
estim high-end price-to-earnings rang promis
growth opportun jun-q ep vs in-lin
estim rais jun ep estim
initi ep jun-q sale increas constant
currenc cc million slightli expect
revenu america exclud saa grew cc year-over-year driven
except growth mask sale america sale europ asia
market grew cc led mask sale rmd gross
margin expand basi point yoy in-lin expect
primarili due contribut matrixcar manufacturing/procur
effici partial off-set declin averag sell price overal
solid quarter expect /kevin huang cfa
et cfra maintain hold opinion share resm inc
lift target base
ep estim toward high end pe
rang promis growth opportun mar-q ep
vs higher estim rais
june ep estim lower ep estim
mar-q sale increas constant currenc
cc million expect revenu
america exclud saa grew cc year-over-year driven growth
mask sale sale europ asia market also grew cc led
mask sale well adjust gross margin expand basi point
bp yoy bp come matrixcar
acquisit begun integr saa asset
believ support compani long-term strategi drive improv
patient outcom busi effici out-of-hospit health care
note research note reflect cfra publish opinion analysi stock time note publish note reflect view equiti analyst date time
indic note may reflect cfra current view compani
redistribut reproduct prohibit without prior written permiss copyright cfra
fiscal year analyst estim earn
usd quarter fiscal year
announc earn per share usd repres
total revenu estim fiscal year
analyst estim earn per share grow
usd
total
estimate
forecast reliabl indic futur perform
note compani earn outlook play major part invest decis global market intellig organ earn estim wall street analyst
provid consensu earn next two year well earn estim chang time note inform provid relat consensu
estim intend predict actual result taken reliabl indic futur perform
note tabl graph chart report cite refer sourc sourc global market intellig
redistribut reproduct prohibit without prior written permiss copyright cfra
sinc januari cfra equiti fund research servic
predecessor capit iq equiti research rank univers
common stock adr american depositari receipt adss american
depositari share base given equiti potenti futur perform
similarli rank asian european equiti sinc june
rank equiti accord individu forecast equiti futur total
return potenti versu expect total return relev benchmark
region index asia europ
base time horizon star design meet need
investor look put invest decis perspect data use
assist determin star rank may result analyst
model well intern proprietari model result dynam data
also known
 growth
stabil earn dividend deem key element establish
global market intellig earn dividend rank common stock
design capsul natur record singl symbol
note howev process also take consider certain
adjust modif deem desir establish rank
final score stock measur score matrix determin
analysi score larg repres sampl stock
rang score array sampl align follow
ladder rank
cfra earn per share ep estim reflect analyst project futur
ep continu oper gener exclud variou item
view special non-recur extraordinari also ep estim reflect
either forecast equiti analyst consensu averag ep estim
independ compil global market intellig data
provid cfra among item typic exclud ep estim
asset sale gain impair restructur merger-rel charg legal
insur settlement process research develop expens gain
loss extinguish debt cumul effect account
chang earn relat oper classifi
compani discontinu inclus item stock option
expens recur type charg may vari depend
factor industri practic analyst judgment extent
type data disclos compani
equiti analyst project market price given secur command
month henc base combin intrins rel privat
cfra equiti research produc distribut account research
analyt llc d/b/a cfra cfra us togeth affili
subsidiari cfra certain research produc distribut cfra
sdn bhd compani formerli known standard poor
malaysia sdn bhd cfra malaysia certain research distribut cfra uk
limit cfra uk cfra uk cfra malaysia wholly-own subsidiari
cfra us
abbrevi use equiti research report
ebit earn interest tax
redistribut reproduct prohibit without prior written permiss copyright cfra
p/nav price net asset valu ratio price-to-earnings-to-growth ratio pv present
 research develop roce return capit employ roe
return equiti
roi return invest
 return invest capit
roa return asset
wacc weight averag capit
dividend american depositori receipt adr american depositori
share adss net tax paid countri origin
reflect equiti analyst view given compani oper risk
risk firm abil continu on-going concern qualit risk
assess rel rank star univers
reflect risk factor relat compani oper oppos risk
volatil measur associ share price etf reflect
capitalization-weight basi averag qualit risk assess
assign hold fund
star rank system definit
total return expect outperform total return relev benchmark
notabl margin come month share rise price
total return expect outperform total return relev benchmark
come month share rise price absolut basi
total return expect close approxim total return relev
benchmark come month share gener rise price
absolut basi
total return expect under-perform total return relev
benchmark come month share price anticip
total return expect under-perform total return relev
benchmark notabl margin come month share fall
price absolut basi
north america relev benchmark europ
asia relev benchmark europ asia
